Oral bioavailability enhancement of flubendazole by developing nanofibrous solid dosage forms-Reference-Cited by-同舟云学术

Oral bioavailability enhancement of flubendazole by developing nanofibrous solid dosage forms

Published:2017-03-08 Issue:7 Volume:43 Page:1126-1133
ISSN:0363-9045
Container-title:Drug Development and Industrial Pharmacy
language:en
Short-container-title:Drug Development and Industrial Pharmacy

Author:

Vigh Tamás¹,Démuth Balázs¹,Balogh Attila¹,Galata Dorián L.¹,Van Assche Ivo²,Mackie Claire²,Vialpando Monica²,Van Hove Ben²,Psathas Petros²,Borbás Enikő¹,Pataki Hajnalka¹,Boeykens Peter²,Marosi György¹,Verreck Geert²,Nagy Zsombor K.¹

Affiliation:

1. Department of Organic Chemistry and Technology, Budapest University of Technology and Economics, Budapest, Hungary;

2. Drug Product Development, Janssen R&D, Beerse, Belgium

Funder

New Széchenyi Plan

Publisher

Informa UK Limited

Subject

Organic Chemistry,Drug Discovery,Pharmaceutical Science,Pharmacology

Link

https://www.tandfonline.com/doi/pdf/10.1080/03639045.2017.1298121

Reference42 articles.

1. World Health Organization. Fact sheet N°102 – lymphatic filariasis. Available from: http://www.who.int/mediacentre/factsheets/fs102/en/ [last accessed 6 Nov 2016].

2. Flubendazole: a candidate macrofilaricide for lymphatic filariasis and onchocerciasis field programs

3. COMPARISON OF FLUBENDAZOLE AND DIETHYLCARBAMAZINE IN TREATMENT OF ONCHOCERCIASIS

4. Chemotherapy

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhanced dissolution rates of glibenclamide through solid dispersions on microcrystalline cellulose and mannitol, combined with phosphatidylcholine;Drug Development and Industrial Pharmacy;2024-02-27

2. Solvent electrospinning amorphous solid dispersions with high itraconazole, celecoxib, mebendazole and fenofibrate drug loading and release potential;Journal of Controlled Release;2023-10

3. Nano-crystallization of flubendazole for enhanced dissolution rate and improved in vivo efficacy against Trichinella spiralis;Pharmaceutical Development and Technology;2023-06-15

4. Development of Robust Tablet Formulations with Enhanced Drug Dissolution Profiles from Centrifugally-Spun Micro-Fibrous Solid Dispersions of Itraconazole, a BCS Class II Drug;Pharmaceutics;2023-03-01

5. Influence of Co-amorphization on the Physical Stability and Dissolution Performance of an Anthelmintic Drug Flubendazole;Molecular Pharmaceutics;2023-02-03